Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CyTuVax B.V.
DescriptionHBV vaccine with depot-attached IL-2 macro-aggregates
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent HBV infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today